Kidney protection study for heart surgery patients
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at a protein in the blood that may help predict kidney damage after heart surgery. It aims to find ways to protect kidney function during and after the operation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are scheduled for elective (planned, not emergency) heart surgery that uses a heart-lung machine.
- You do not have severe chronic kidney disease (with a filtration rate below 20).
- You have not had acute kidney injury (sudden kidney damage) in the last 30 days.
- You are not taking medications that block vascular endothelial growth factor (a protein that promotes blood vessel growth).
- You are not on medications to support blood pressure or heart function before surgery, and you have not had a cardiac arrest in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at why some people develop kidney damage after heart surgery that uses a heart-lung machine. It aims to help doctors better predict and prevent this complication.
This study tests a treatment called RenalGuard to help protect your kidneys from damage that can happen after heart surgery. It may be helpful if you have certain risk factors like diabetes or kidney disease.
This study looks at how your body's metabolism (energy use) can predict if you'll get kidney damage after heart surgery. It aims to help doctors identify high-risk patients earlier so they can prevent or treat kidney problems sooner.
This study looks at whether certain markers in the blood or urine can help predict if kidney problems after heart surgery will get worse. It aims to find better ways to monitor and manage kidney health after surgery.
This trial looks at whether a specific heart-surgery technique (called CLCVP) can help protect kidney function soon after surgery. It is mainly for adults with otherwise normal kidney tests before certain types of heart operations.
This study looks for early signs in your blood or urine that can predict if you might develop kidney damage after heart or blood vessel surgery. It aims to help doctors identify high-risk patients earlier so they can protect their kidneys.
Hear when a new Acute Kidney Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.